Zynerba Pharmaceuticals Inc (ZYNE)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

80 W. LANCASTER AVENUE DEVON, PA 19333

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company develops next-generation synthetic cannabinoid therapeutics for transdermal delivery for patients with significant unmet medical needs. Zynerba Pharmaceuticals serves the healthcare sector and patients in the United States.

Data as of 2020-05-24
Market Cap161.68 Million Shares Outstanding24.951 Million Avg 30-day Volume906.601 Thousand
P/E Ratio Dividend Yield EPS-1.58
Price/Sales Price cash flow ratio Price free cash flow ratio-4.4
Book Value2.65 Price to Tangible Book2.44 Alpha
Short Interest Ratio % Short Interest to Float R-squared
BETA 52-week High/Low15.6973 / 2.55 Stddev
View SEC Filings from ZYNE instead.

View recent insider trading info

Funds Holding ZYNE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ZYNE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

STEPHENSON PAMELA CHIEF COMMERCIAL OFFICER

  • Officer
23,215 2020-03-25 1

BUTLER JOHN P. CEO AND PRESIDENT

1,308,582 2020-02-28 1

ANIDO ARMANDO CHAIRMAN & CHIEF EXEC. OFFICER

  • Officer
  • Director
0 2020-01-30 1

SEBREE TERRI B PRESIDENT

  • Officer
0 2020-01-30 1

HANLON SUZANNE M. SEC, VP & GENERAL COUNSEL

  • Officer
0 2020-01-30 1

FICKENSCHER JAMES E CHIEF FINANCIAL OFFICER

  • Officer
0 2020-01-30 1

ROSENBERGER BRIAN VP, COMMERCIAL & BUSINESS DEV.

  • Officer
0 2020-01-30 1

MOCH KENNETH I

  • Director
0 2019-10-01 3

KISNER DANIEL L

  • Director
0 2019-09-12 1

FEDERICI WILLIAM J

  • Director
0 2019-06-11 1

COOPER WARREN D

  • Director
0 2019-06-11 1

HARRISON THOMAS L

  • Director
0 2018-06-06 0

RAPP MICHAEL

  • 10% Owner
1,500,000 2018-05-30 0

RASK CYNTHIA ANN

  • Director
0 2017-07-03 0

BARON RICHARD A CHIEF FINANCIAL OFFICER

  • Officer
15,957 2015-09-11 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions

Elevate your investments